| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/10/2006 | CA2277520C Nucleic acid sequencing |
| 10/10/2006 | CA2274307C Hypersensitive response induced resistance in plants by seed treatment |
| 10/10/2006 | CA2238964C Plants having mutant sequences that confer altered fatty acid profiles |
| 10/10/2006 | CA2238277C Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 10/10/2006 | CA2212887C Monoclonal antibody specific for .beta.a4 peptide |
| 10/10/2006 | CA2192324C Recombinant virus and related method of quantitating same |
| 10/10/2006 | CA2175703C Alteration of sequence of a target molecule |
| 10/10/2006 | CA2075388C Modification of sucrose accumulation in potato tubers |
| 10/08/2006 | CA2540736A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/08/2006 | CA2503932A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/06/2006 | CA2602185A1 Enzymes and formulations for broad-specificity decontamination of chemical and biological warfare agents |
| 10/05/2006 | WO2006105540A2 Methods of identifying aberrant rna or rna targeted for cleavage by mirna or sirna |
| 10/05/2006 | WO2006105483A2 Mutant dna polymerases and methods of use |
| 10/05/2006 | WO2006105436A2 Cloning and characterization of micrornas from rice |
| 10/05/2006 | WO2006105392A2 Neuron targeting peptides |
| 10/05/2006 | WO2006105361A2 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 10/05/2006 | WO2006105343A2 Dkkl-i splice product modulators for cancer diagnosis and therapy |
| 10/05/2006 | WO2006105339A2 Gene synthesis using pooled dna |
| 10/05/2006 | WO2006105277A2 Eg1117 and eg307 polynucleotides and uses thereof |
| 10/05/2006 | WO2006105251A2 Electrosonic cell manipulation device and method of use thereof |
| 10/05/2006 | WO2006105044A1 Suicidal mutant leishmania vaccine |
| 10/05/2006 | WO2006104913A2 USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN |
| 10/05/2006 | WO2006104891A2 Methods and genetic constructs for modification of lignin composition of corn cobs |
| 10/05/2006 | WO2006104615A2 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/05/2006 | WO2006104503A1 Stress tolerant transgenic plants over-expressing genes of ascorbic acid synthesis-cell wall |
| 10/05/2006 | WO2006104254A1 Method for screening of receptor-binding substance |
| 10/05/2006 | WO2006104213A1 Reaction vessel, reaction vessel processing apparatus and diagnostic apparatus |
| 10/05/2006 | WO2006104200A1 Fluorescent protein |
| 10/05/2006 | WO2006104186A1 Dipeptide crystal and method for producing same |
| 10/05/2006 | WO2006104124A1 Novel pantothenate kinase gene and use thereof |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006104085A1 Monoclonal antibody specific to denatured human leukocyte antigen class i |
| 10/05/2006 | WO2006104035A1 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene |
| 10/05/2006 | WO2006104031A1 Method of detecting mycoplasma |
| 10/05/2006 | WO2006103826A1 Probe array and process for producing probe array |
| 10/05/2006 | WO2006103772A1 High-affinity rna aptamer molecule for glutathione s-transferase protein |
| 10/05/2006 | WO2006103569A2 Expression vectors and methods for obtaining nk cell specific expression |
| 10/05/2006 | WO2006103494A2 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 10/05/2006 | WO2006103472A2 Soluble vox2 protein as immunoregulatory factor |
| 10/05/2006 | WO2006103429A2 High affinity hiv t cell receptors |
| 10/05/2006 | WO2006103107A1 Phosphorylated waxy potato starch |
| 10/05/2006 | WO2006103094A2 Method for treating a sample that contains biomolecules |
| 10/05/2006 | WO2006102970A2 Modified short interfering rna |
| 10/05/2006 | WO2006102767A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | WO2006102755A1 Identification of a sterol acyltransferase gene |
| 10/05/2006 | WO2006102720A1 Isolation of inhibitor of ires-mediated translation |
| 10/05/2006 | WO2006081553A3 ANTI-MUC1 α/ß ANTIBODIES |
| 10/05/2006 | WO2006079546A3 Production of antibodies in plants with plus -sense single -stranded viral rna vectors |
| 10/05/2006 | WO2006079045A9 Evaluation of salt tolerance in transgenic arabidopsis plants expressing sos2 mutant alleles . |
| 10/05/2006 | WO2006077112A8 Sirna molecules for treatment of blood vessels |
| 10/05/2006 | WO2006075084A3 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 10/05/2006 | WO2006073431A9 Avipox recombinants expressing foot and mouth disease virus genes |
| 10/05/2006 | WO2006071203A3 L-arabinose isomerase exhibiting minimum dependence on metal ions for its activity and for thermostability, isolated and characterized nucleotide sequence thereof |
| 10/05/2006 | WO2006066049A3 Humanized antibodies that recognize beta amyloid peptide |
| 10/05/2006 | WO2006061173A3 Melibiose operon expression system |
| 10/05/2006 | WO2006059145A3 Transgenic animals with reduced major urinary protein production |
| 10/05/2006 | WO2006052591A3 Anti-properdin antibodies, and methods for making and using same |
| 10/05/2006 | WO2006047301A3 Parvovirus methods and compositions for killing neoplastic cells |
| 10/05/2006 | WO2006044045A3 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications |
| 10/05/2006 | WO2006039073A3 Methods and compositions for reducing a level of a toxic protein in a cell |
| 10/05/2006 | WO2006028889A3 Systems and methods for protein production |
| 10/05/2006 | WO2006020849A3 Mutant interleukin-15 polypeptides |
| 10/05/2006 | WO2006018857A3 Methods for plant regeneration, transformation and production of insect resistant transgenic okra |
| 10/05/2006 | WO2006005032A3 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 10/05/2006 | WO2005086658A3 Processes for adenovirus purification using continuous flow centrifugation |
| 10/05/2006 | WO2005082088A3 Functional genomics and gene trapping in haploid or hypodiploid cells |
| 10/05/2006 | WO2005062942A3 Novel oligonucleotides and treating cardiac disorders by using the same |
| 10/05/2006 | WO2004058052A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 10/05/2006 | WO2004046317A3 Products and processes for modulating peptide-peptide binding domain interactions |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | WO2004038030A3 Bioabsorbable polymer containing 2-hdroxyacid monomers |
| 10/05/2006 | WO2003106643A8 Novel polynucleotides encoding lamprey gnrh-iii |
| 10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/05/2006 | WO2003086052A3 Low allergen plant and animal genotypes |
| 10/05/2006 | WO2003004992A3 Mammalian sweet and amino acid heterodimeric taste receptors |
| 10/05/2006 | US20060225160 Soybean variety XB25G06 |
| 10/05/2006 | US20060225159 Canola cultivar NQC02CNX13 |
| 10/05/2006 | US20060225157 Canola variety SW 013154 |
| 10/05/2006 | US20060225155 Method for the production of stably transformed, fertile gramineae employing agrobacterium-mediated transformation of isolated gramineae zygotes |
| 10/05/2006 | US20060225154 Method for increasing expression of stress defense genes |
| 10/05/2006 | US20060225153 EG1117 and EG307 polynucleotides and uses thereof |
| 10/05/2006 | US20060225152 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 10/05/2006 | US20060225151 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 10/05/2006 | US20060225150 Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance |
| 10/05/2006 | US20060225149 Transgenic plant comprising vector coding p.parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control; progenitor cells a vector is introduced into plant, growing a transgenic plant that expresses the nucleotide sequence |
| 10/05/2006 | US20060225148 Plastid transit peptides |
| 10/05/2006 | US20060225147 DNA fragment which comprises an EPSPS 5' regulatory sequence and a glyphosate-resistant EPSPS coding sequence is introduced into regenerable plant cells; DNA fragment used for transformation preferably comprises modified plant genomic sequence |
| 10/05/2006 | US20060225146 Canola cultivar NQC02CNX21 |
| 10/05/2006 | US20060225145 Regulating the concentration of nitrate in the environment of a transgenic plant; nucleotide sequence expressing a nitrate transporter proteins |
| 10/05/2006 | US20060225144 Isolated nucleic acid molecule encoding a cis-prenyltransferase enzyme; altering natural rubber production in transgenic plants |
| 10/05/2006 | US20060225143 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 10/05/2006 | US20060224331 Protein fragment complementation assays for high-throughput and high-content screening |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223987 Neutrophil specific immunoglobulins for use in treatment and prevention of microbial infection |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223778 Circular nucleic acid vectors, and methods for making and using the same |
| 10/05/2006 | US20060223777 Highly functional short hairpin RNA |
| 10/05/2006 | US20060223775 Nucleotide sequence for treating cancer and infection |
| 10/05/2006 | US20060223774 therapy for bacteria infections which ar drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acid |